Dynavax Technologies | DVAX - Trade Creditors


Dynavax Technologies reported $3.95M in Trade Creditors for its fiscal quarter ending in September of 2025.



Trade Creditors Change Date
AbbVie USD 32.25B 1.2B Jun/2025
Adma Biologics USD 24.02M 5.75M Sep/2025
Agenus USD 85.29M 10.89M Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
Glaxosmithkline GBP 21.07B 7.42B Sep/2025
Merck USD 4.15B 102M Sep/2025
Minerva Neurosciences USD 945K 48K Sep/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Neurocrine Biosciences USD 545.5M 425.6M Dec/2025
Novartis USD 4.56B 49M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025